Your browser doesn't support javascript.
loading
Dabrafenib plus trametinib in BRAF K601E-mutant melanoma.
Rogiers, A; Thomas, D; Vander Borght, S; van den Oord, J J; Bechter, O; Dewaele, M; Rambow, F; Marine, J-C; Wolter, P.
Afiliação
  • Rogiers A; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium.
  • Thomas D; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Vander Borght S; Laboratory for Therapeutic and Diagnostic Antibodies/PharmAbs, KU Leuven, Leuven, Belgium.
  • van den Oord JJ; Department of Human Genetics, Center for Human Genetics, KU Leuven, Leuven, Belgium.
  • Bechter O; Department of Pathology, University Hospitals, KU Leuven, Leuven, Belgium.
  • Dewaele M; Department of Pathology, University Hospitals, KU Leuven, Leuven, Belgium.
  • Rambow F; Department of General Medical Oncology, KU Leuven, Leuven, Belgium.
  • Marine JC; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium.
  • Wolter P; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
Br J Dermatol ; 180(2): 421-422, 2019 02.
Article em En | MEDLINE | ID: mdl-30248172

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oximas / Piridonas / Pirimidinonas / Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Imidazóis / Melanoma Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oximas / Piridonas / Pirimidinonas / Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Imidazóis / Melanoma Idioma: En Ano de publicação: 2019 Tipo de documento: Article